These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 17428657)

  • 1. Potent bradykinin B1 receptor antagonists: 4-substituted phenyl cyclohexanes.
    Su DS; Lim JL; Markowitz MK; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Tang C; Prueksaritanont T; Freidinger RM; Bock MG
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3006-9. PubMed ID: 17428657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclopropylamino acid amide as a pharmacophoric replacement for 2,3-diaminopyridine. Application to the design of novel bradykinin B1 receptor antagonists.
    Wood MR; Schirripa KM; Kim JJ; Wan BL; Murphy KL; Ransom RW; Chang RS; Tang C; Prueksaritanont T; Detwiler TJ; Hettrick LA; Landis ER; Leonard YM; Krueger JA; Lewis SD; Pettibone DJ; Freidinger RM; Bock MG
    J Med Chem; 2006 Feb; 49(4):1231-4. PubMed ID: 16480259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2,3-diaminopyridine bradykinin B1 receptor antagonists.
    Kuduk SD; Ng C; Feng DM; Wai JM; Chang RS; Harrell CM; Murphy KL; Ransom RW; Reiss D; Ivarsson M; Mason G; Boyce S; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
    J Med Chem; 2004 Dec; 47(26):6439-42. PubMed ID: 15588075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new class of bradykinin 1 receptor antagonists containing the piperidine acetic acid tetralin core.
    Fotsch C; Biddlecome G; Biswas K; Chen JJ; D'Amico DC; Groneberg RD; Han NB; Hsieh FY; Kamassah A; Kumar G; Lester-Zeiner D; Liu Q; Mareska DA; Riahi BB; Wang YJ; Yang K; Zhan J; Zhu J; Johnson E; Ng G; Askew BC
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2071-5. PubMed ID: 16464576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Aminobenzophenones as a novel class of bradykinin B1 receptor antagonists.
    Su DS; Lim JL; Tinney E; Wan BL; Murphy KL; Reiss DR; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Pettibone DJ; Yu J; Tang C; Prueksaritanont T; Freidinger RM; Bock MG; Anthony NJ
    J Med Chem; 2008 Jul; 51(13):3946-52. PubMed ID: 18553956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of orally bioavailable and CNS penetrant biphenylaminocyclopropane carboxamide bradykinin B1 receptor antagonists.
    Kuduk SD; Di Marco CN; Chang RK; Wood MR; Schirripa KM; Kim JJ; Wai JM; DiPardo RM; Murphy KL; Ransom RW; Harrell CM; Reiss DR; Holahan MA; Cook J; Hess JF; Sain N; Urban MO; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    J Med Chem; 2007 Jan; 50(2):272-82. PubMed ID: 17228869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.
    Su DS; Markowitz MK; DiPardo RM; Murphy KL; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Ha S; Hess FJ; Pettibone DJ; Mason GS; Boyce S; Freidinger RM; Bock MG
    J Am Chem Soc; 2003 Jun; 125(25):7516-7. PubMed ID: 12812482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent nonpeptide antagonists of the bradykinin B1 receptor: structure-activity relationship studies with novel diaminochroman carboxamides.
    Biswas K; Li A; Chen JJ; D'Amico DC; Fotsch C; Han N; Human J; Liu Q; Norman MH; Riahi B; Yuan C; Suzuki H; Mareska DA; Zhan J; Clarke DE; Toro A; Groneberg RD; Burgess LE; Lester-Zeiner D; Biddlecome G; Manning BH; Arik L; Dong H; Huang M; Kamassah A; Loeloff R; Sun H; Hsieh FY; Kumar G; Ng GY; Hungate RW; Askew BC; Johnson E
    J Med Chem; 2007 May; 50(9):2200-12. PubMed ID: 17408249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
    J Med Chem; 1998 Oct; 41(21):4062-79. PubMed ID: 9767643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 2. Overcoming the species difference between guinea pig and man.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Hatori C; Sawai H; Oku T; Tanaka H
    J Med Chem; 1998 Oct; 41(21):4053-61. PubMed ID: 9767642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl sulfones as novel bradykinin B1 receptor antagonists for treatment of chronic pain.
    Biswas K; Aya T; Qian W; Peterkin TA; Chen JJ; Human J; Hungate RW; Kumar G; Arik L; Lester-Zeiner D; Biddlecome G; Manning BH; Sun H; Dong H; Huang M; Loeloff R; Johnson EJ; Askew BC
    Bioorg Med Chem Lett; 2008 Sep; 18(17):4764-9. PubMed ID: 18706809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological, pharmacokinetic, and primate analgesic efficacy profile of the novel bradykinin B1 Receptor antagonist ELN441958.
    Hawkinson JE; Szoke BG; Garofalo AW; Hom DS; Zhang H; Dreyer M; Fukuda JY; Chen L; Samant B; Simmonds S; Zeitz KP; Wadsworth A; Liao A; Chavez RA; Zmolek W; Ruslim L; Bova MP; Holcomb R; Butelman ER; Ko MC; Malmberg AB
    J Pharmacol Exp Ther; 2007 Aug; 322(2):619-30. PubMed ID: 17470643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3-Diaminopyridine as a platform for designing structurally unique nonpeptide bradykinin B1 receptor antagonists.
    Feng DM; Wai JM; Kuduk SD; Ng C; Murphy KL; Ransom RW; Reiss D; Chang RS; Harrell CM; MacNeil T; Tang C; Prueksaritanont T; Freidinger RM; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2005 May; 15(9):2385-8. PubMed ID: 15837330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical synthesis of a potent bradykinin B(1) antagonist via enantioselective hydrogenation of a pyridyl N-acyl enamide.
    O'Shea PD; Gauvreau D; Gosselin F; Hughes G; Nadeau C; Roy A; Shultz CS
    J Org Chem; 2009 Jun; 74(12):4547-53. PubMed ID: 19456171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin B1 antagonists: biphenyl SAR studies in the cyclopropanecarboxamide series.
    Kuduk SD; DiPardo RM; Chang RK; Di Marco CN; Murphy KL; Ransom RW; Reiss DR; Tang C; Prueksaritanont T; Pettibone DJ; Bock MG
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3608-12. PubMed ID: 17482459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of pyrazoline derivatives as new anti-inflammatory and analgesic agents.
    Amir M; Kumar H; Khan SA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):918-22. PubMed ID: 18182288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From bradykinin B2 receptor antagonists to orally active and selective bradykinin B1 receptor antagonists.
    Barth M; Bondoux M; Luccarini JM; Peyrou V; Dodey P; Pruneau D; Massardier C; Paquet JL
    J Med Chem; 2012 Mar; 55(6):2574-84. PubMed ID: 22369198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antinociceptive pharmacology of N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl) sulfonyl]methylamino]ethoxy]-N-methylacetamide, fumarate (LF22-0542), a novel nonpeptidic bradykinin B1 receptor antagonist.
    Porreca F; Vanderah TW; Guo W; Barth M; Dodey P; Peyrou V; Luccarini JM; Junien JL; Pruneau D
    J Pharmacol Exp Ther; 2006 Jul; 318(1):195-205. PubMed ID: 16565167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a nonpeptidic and conformationally restricted bradykinin B1 receptor antagonist with anti-inflammatory activity.
    D'Amico DC; Aya T; Human J; Fotsch C; Chen JJ; Biswas K; Riahi B; Norman MH; Willoughby CA; Hungate R; Reider PJ; Biddlecome G; Lester-Zeiner D; Staden CV; Johnson E; Kamassah A; Arik L; Wang J; Viswanadhan VN; Groneberg RD; Zhan J; Suzuki H; Toro A; Mareska DA; Clarke DE; Harvey DM; Burgess LE; Laird ER; Askew B; Ng G
    J Med Chem; 2007 Feb; 50(4):607-10. PubMed ID: 17243660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule bradykinin B1 receptor antagonists as potential therapeutic agents for pain.
    Chen JJ; Biswas K
    Prog Med Chem; 2008; 46():173-204. PubMed ID: 18381126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.